Discover point-of-care tools like our insurance coverage checker for CGMs and medications and dosing info for T2D

Resource Library


Filter by tags

AbbottAppsBillingBookCGM Data SharingClinical GuidelinesCMECreated By MCT2DDexcomDiet DoctorHow-toKidneyLower CarbMCT2D RecommendedMedicareMember RecommendedNon-videoPDFPoint-of-carePresentationsPrior AuthPublished LiteratureSoftwareSpanishVideosWebWeb Tutorial







Lower Carbohydrate Eating: A Free Starter Guide for Patients

A point-of-care tool to print and share with patients who are curious about low carb. In simple language, this document compares lower versus higher carb meals and their impact on hunger, cravings, and blood sugar levels. It provides tips to get started with evaluating one’s diet and swapping higher carbohydrate foods with lower carb options. It also provides a visual guide to evaluating the carb content of one’s meal.
Developed by MCT2D dietitian, clinicians, and design team, this tool was evaluated and co-designed with our Patient Advisory Board in April/May 2022.

Medications and CGM Coverage by Payer in Michigan 2022 Quick Reference Guide

Last updated 8/22/2022 (Q2)
Quickly reference insurance provider coverage of SGLT-2 Inhibitors and GLP1-Receptor Agonists as well as CGMs. Providers include private Blue Cross Blue Shield of Michigan, HAP, Priority Health, and United Plans, as well as public Medicare, Medicare Advantage, and Medicaid coverage. Pharmacy carve out coverage information is forthcoming.
Developed by the Michigan Collaborative for Type 2 Diabetes.

Affording your Type 2 Diabetes Care: A Patient Toolkit on Insurance Coverage and Cost

A all-in-one printable booklet designed for patients that will walk you through important aspects of insurance coverage for type 2 diabetes treatments like medication and continuous glucose monitors (CGM). This packet includes a worksheet of questions to ask your insurance company, plain language definitions to understand coverage, and guides to pharmacy discount programs. A great resource to print and have on hand for clinical pharmacists, care managers, MAs, and clinical staff who support patients as they navigate the costs of care.

Patient Assistance Program (PAP) Guide for Patients with Medicare Part D

Your patient may qualify for free medications as part of each drug manufacturer’s patient assistance program (PAP). Use this guide for patients who have Medicare Part D to find the right PAP and overview of the program’s qualifications and application process.

MCT2D Clinician Decision Aid: SGLT-2 Inhibitor / GLP-1 RA for Type 2 Diabetes

Why this aid?
SGLT2-inhibitors and GLP-1 receptor agonists are two newer classes of medications for diabetes that reduce hyperglycemia, reduce endogenous insulin production, and improve cardiovascular and renal outcomes, weight loss, and mortality in Type 2 Diabetes.
This aid is meant to be used alongside your own clinical judgment and prescribing information to guide individualization of diabetes treatment.

MCT2D Resource: Dosing Information for SGLT-2 Inhibitors and GLP-1 Receptor Agonists for Type 2 Diabetes

Key dosing information for SGLT2-I and GLP1-RAs including dose escalation, pen and needle RX considerations, proven benefits for ASCVD, CKD, HFrEF, HFpEF, and DKD.

Subscribe to the MCT2D Newsletter

* indicates required
Blue Cross Blue Shield Blue Care Network of Michigan

Support for the Michigan Collaborative on Type 2 Diabetes is provided by Blue Cross Blue Shield of Michigan and Blue Care Network as part of the BCBSM Value Partnerships program. BCBSM’s Value Partnerships program provides clinical and executive support for all CQI programs. To learn more about Value Partnerships, visit Although Blue Cross Blue Shield of Michigan and the Michigan Collaborative on Type 2 Diabetes work in partnership, the opinions, beliefs, and viewpoints expressed by MCT2D do not necessarily reflect the opinions, beliefs, and viewpoints of BCBSM or any of its employees.